Dialogues in Clinical Neuroscience · 2014 · 89 citations · 61 references
MedicineGeneticsPsychiatryPharmacogeneticsPharmacogenomicsPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyClinical Implementation Of PharmacogeneticsPharmacogenetic TestingPsychiatric GeneticsAntipsychotic EfficacyAntipsychotic PharmacogenomicsInterindividual Variability AnalysisPersonalized Treatment SelectionPharmacogenetic StudiesSide Effect ProfileTranslational PharmacogeneticsVariability In Antipsychotic Response
Antipsychotic medications are the gold-standard treatment for schizophrenia, and are often prescribed for other mental conditions. However, the efficacy and side-effect profiles of these drugs are heterogeneous, with large interindividual variability. As a result, treatment selection remains a largely trial-and-error process, with many failed treatment regimens endured before finding a tolerable balance between symptom management and side effects. Much of the interindividual variability in response and side effects is due to genetic factors (heritability, h(2)~ 0.60-0.80). Pharmacogenetics is an emerging field that holds the potential to facilitate the selection of the best medication for a particular patient, based on his or her genetic information. In this review we discuss the most promising genetic markers of antipsychotic treatment outcomes, and present current translational research efforts that aim to bring these pharmacogenetic findings to the clinic in the near future.
61
A "Silent" Polymorphism in the <i>MDR</i> 1 Gene Changes Substrate Specificity
Chava Kimchi‐Sarfaty, Jung Mi Oh, In‐Wha Kim et al. · Science · 2006 · 2.5K citations · Full text
The Path to Personalized Medicine
Margaret Hamburg, Francis S. Collins · New England Journal of Medicine · 2010 · 1.9K citations · Full text
Genome-wide association analysis identifies 13 new risk loci for schizophrenia
Stephan Ripke, Colm Ó'Dúshláine, Kimberly Chambert et al. · Nature Genetics · 2013 · 1.6K citations · Full text